Basic and Clinical Pharmacology 14th Edition Katzung Trevor Test Bank.

BasiccvandcvClinicalcvPharmacologycv14thcvEditioncvKatzungcvTrevorcvTestcvBank
FULLcvTESTBANK


RRRRRRINSTANTcvDOWNLOAD!!

,BasiccvandcvClinicalcvPharmacologycv14thcvEditioncvKatzungcvTrevorcvTestc v Ba
nk




Chaptercv1.cvIntroduction:cvThecvNaturecvofcvDrugscv&cvDrugcvDevelopmentcv&cvRegulation


1.
Acvnursecvworkingcvincvradiologycvadministerscviodinecvtocvacvpatientcvwhocv
iscvhavingcvacvcomputedcvtomographycv(CT)cvscan.cvThecvnursecvworkingcvoncv
thecvoncologycvunitcvadministerscvchemotherapycvtocvpatientscvwhocvhavecvcan
cer.cvAtcvthecvPubliccvHealthcvDepartment,cvacvnursecvadministerscvacvmeasles-
mumps-rubellacv(MMR)cvvaccinecvtocvacv14-month-
oldcvchildcvascvacvroutinecvimmunization.cvWhichcvbranchcvofcvpharmacologycv
bestcvdescribescvthecvactionscvofcvallcvthreec v nurses?
A) Pharmacoeconomics

B) Pharmacotherapeutics

C) Pharmacodynamics

D) Pharmacokinetics

Ans: B

Feedback:

Pharmacologycviscvthecvstudycvofcvthecvbiologiccveffectscvofcvchemicals.cvNurs
escvarecvinvolvedcvwithcvclinicalcvpharmacologycvorcvpharmacotherapeutics,cv
whichcviscvacvbranchcvofcvpharmacologycvthatcvdealscvwithcvthecvusescvofcvdrug
scvtocvtreat,cvprevent,cvandcvdiagnosecvdisease.cvThecvradiologycvnursecviscvadm
inisteringcvacvdrugcvtocvhelpcvdiagnosecvacvdisease.cvThecvoncologycvnursecviscva
dministeringcvacvdrugcvtocvhelpcvtreatcvacvdisease.cvPharmacoeconomicscvinclud
escvanycvcostscvinvolvedcvincvdrugcvtherapy.
Pharmacodynamicscvinvolvescvhowcvacvdrugcvaffectscvthecvbodycvandcvpharmac
okineticscviscvhowcvthecvbodycvactscvoncvthecvbody.

,2.
Acvphysiciancvhascvorderedcvintramuscularcv(IM)cvinjectionscvofcvmorphine,
a narcotic,cveverycv4cvhourscvascvneededcvforcvpaincvincvacvmotorcvvehiclecvac
cv cv

cidentcvvictim.cvThecvnursecviscvawarecvthiscvdrugcvhascvacvhighcvabusecvpotenti
al.cvUndercvwhatcvcategorycvwouldcvmorphinecvbecvclassified?
A) SchedulecvI

B) SchedulecvII

C) SchedulecvIII

D) SchedulecvIV

Ans: B

Feedback:

NarcoticscvwithcvacvhighcvabusecvpotentialcvarecvclassifiedcvascvSchedulecvIIcv
drugscvbecausecvofcvseverecvdependencecvliability.cvSchedulecvIcvdrugscvhavec
vhighcvabusecvpotentialcvandcvnocvacceptedcvmedicalcvuse.cvSchedulecvIIIcvdru

gscvhavecvacvlessercvabusecvpotentialcvthancvIIcvandcvancvacceptedcvmedicalcvus
e.cvSchedulecvIVcvdrugscvhavecvlowcvabusecvpotentialcvandcvlimitedcvdependen
cecvliability.


3.
WhencvinvolvedcvincvphasecvIIIcvdrugcvevaluationcvstudies,cvwhatcvrespon
sibilitiescvwouldcvthecvnursecvhave?
A) Workingcvwithcvanimalscvwhocvarecvgivencvexperimentalc v drugs

B) Choosingcvappropriatecvpatientscvtocvbecvinvolvedcvincvthecvdrugc v study

C) Monitoringcvandcvobservingcvpatientscvcloselycvforcvadversec v effects

D) Conductingcvresearchcvtocvdeterminecveffectivenesscvofcvthec v drug

Ans: C

Feedback:

, PhasecvIIIcvstudiescvinvolvecvusecvofcvacvdrugcvincvacvvastcvclinicalcvpopulationcv
incvwhichcvpatientscvarecvaskedcvtocvrecordcvanycvsymptomscvtheycvexperiencec
vwhilecvtakingcvthecvdrugs.cvNursescvmaycvbecvresponsiblecvforcvhelpingcvcolle

ctcvandcvanalyzecvthecvinformationcvtocvbecvsharedcvwithcvthecvFoodcvandcvDrugc
vAdministrationcv(FDA)cvbutcvwouldcvnotcvconductcvresearchcvindependentlycv

becausecvnursescvdocvnotcvprescribecvmedications.cvUsecvofcvanimalscvincvdrugc
vtestingcviscvdonecvincvthecvpreclinicalcvtrials.cvSelectcvpatientscvwhocvarecvinvo

lvedcvincvphasecvIIcvstudiescvtocvparticipatecvincvstudiescvwherecvthecvparticipan
tscvhavecvthecvdiseasecvthecvdrugcviscvintendedcvtocvtreat.cvThesecvpatientscvarecv
monitoredcvcloselycvforcvdrugcvactioncvandcvadversecveffects.cvPhasecvIcvstudie
scvinvolvecvhealthycvhumancvvolunteerscvwhocvarecvusuallycvpaidcvforcvtheircvp
articipation.cvNursescvmaycvobservecvforcvadversecveffectscvandcvtoxicity.


4.
Whatcvconceptcviscvconsideredcvwhencvgenericcvdrugscvarecvsubstitutedcv
forcvbrandcvnamecvdrugs?
A) Bioavailability

B) Criticalcvconcentration

C) Distribution

D) Half-life

Ans: A

Feedback:

Bioavailabilitycviscvthecvportioncvofcvacvdosecvofcvacvdrugcvthatcvreachescvthecvs
ystemiccvcirculationcvandcviscvavailablecvtocvactcvoncvbodycvcells.cvBinderscvus
edcvincvacvgenericcvdrugcvmaycvnotcvbecvthecvsamecvascvthosecvusedcvincvthecvbr
andcvnamecvdrug.cvTherefore,cvthecvwaycvthecvbodycvbreakscvdowncvandcvusesc
vthecvdrugcvmaycvdiffer,cvwhichcvmaycveliminatecvacvgenericcvdrugcvsubstitutio

n.cvCriticalcvconcentrationcviscvthecvamountcvofcvacvdrugcvthatcviscvneededcvtocv
causecvacvtherapeuticcveffectcvandcvshouldcvnotcvdiffercvbetweencvgenericcvand
cvbrandcvnamecvmedications.cvDistributioncviscvthecvphasecvofcvpharmacokinet

ics,cvwhichcvinvolvescvthecvmovementcvofcvacvdrugcvtocvthecvbodyscvtissuescva
ndcviscvthecvsamecvincvgenericcvandcvbrandcvnamecvdrugs.cvAcvdrugscvhalf-
lifecviscvthecvtimecvitcvtakescvforcvthecvamountcvofcvdrugcvtocvdecreasecvtocvhalfc
vthecvpeakcvlevel,cvwhichcvshouldcvnotcvchangecvwhencvsubstitutingcvacvgeneri

cc v medication.